Eris Lifesciences Limited (NSEI:ERIS) agreed to acquire additional 19% stake in Swiss Parenterals Limited from Amit Indubhushan Bakshi, Inderjeet Singh Negi, Kaushal Kamlesh Shah and Rajendra Rambhai Patel for INR 2.4 billion on March 14, 2024. Eris Lifesciences acquired 1.060512 million shares in Swiss Parenterals. Prior to the transaction, Eris Lifesciences Limited (NSEI:ERIS) held 51%. Under the terms, 4.75% Equity shares individually is being acquired from four promoters aggregating to 19% stake in Swiss Parenterals. The transaction is expected to close on September 30, 2024 and is approved by board of Eris Lifesciences on March 14, 2024.
Eris Lifesciences Limited (NSEI:ERIS) completed the acquisition of additional 19% stake in Swiss Parenterals Limited from Amit Indubhushan Bakshi, Inderjeet Singh Negi, Kaushal Kamlesh Shah and Rajendra Rambhai Patel on June 11, 2024.